Last reviewed · How we verify
NCT05361681: eCarII
EMI and CIED: Is High Power Charging of Battery Electric Car Safe?
NA trial testing Electromagnetic Field Exposure in Pacemaker in 100 participants. Status unknown.
1 July 2022
Quick facts
| Lead sponsor | Deutsches Herzzentrum Muenchen |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 100 |
| Start date | 1 June 2021 |
| Primary completion | 1 July 2022 |
| Estimated completion | 1 September 2022 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Electromagnetic Field Exposure
Conditions studied
Sponsor
Deutsches Herzzentrum Muenchen — full company profile →
Who can join
18 and older, any sex, with Pacemaker or ICD. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
It is not known if the use of high power charging systems for electric vehicles may interfere with the functionality of implanted pacemakers and cardioverter-defibrillators.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
High-power chargers for electric vehicles: are they safe for patients with pacemakers and defibrillators?
Lennerz C, Schaarschmidt C, Blažek P, Knoll K, et al · · 2023 · cited 4× · PMID 37067822 · DOI 10.1093/europace/euad042
Verify or expand the search:
- PubMed search for NCT05361681
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pacemaker
Currently open trials in the same condition.
- NCT07342036 — Prospective Study of Lead-associated Tricuspid Regurgitation in Patients Undergoing New Transvalvular Lead Insertion · recruiting
- NCT06299514 — RAFT - Pace &Ablate · NA · recruiting
- NCT06330675 — Correct Mobilization Time After Implantation of an Intracardiac Electronic Device Implantation · NA · recruiting
- NCT03636230 — Remote Patient Management of CIEDs - Brady Devices · NA · recruiting
- NCT04201015 — Optimising Pacing for Contractility 2 · Phase 2, PHASE3 · recruiting
Other Deutsches Herzzentrum Muenchen trials
Trials by the same sponsor.
- NCT07344480 — Retrospective Natural History Study of RASopathy-associated Cardiomyopathy (RAS-CM) · recruiting
- NCT06369142 — Intracoronary Stenting and Additional Results Achieved by ShockWAVE Coronary Lithotripsy · NA · recruiting
- NCT06753227 — Invasive Versus Echocardiography-derived Transvalvular Gradients After TAVI Usign Balloon-expandable Transcatheter Heart · enrolling by invitation
- NCT06814574 — Pacemaker Implantation Following Transcatheter Tricuspid Valve Replacement · recruiting
- NCT06060912 — LAmbre Versus AMPLATZER Amulet Left AtrIal Appendage Occluder for StRoke ProphylaxIs · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05361681 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Deutsches Herzzentrum Muenchen
- Last refreshed: 5 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05361681.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing